Earnings Call · Q1 FY2024·2024-05-09

Q1 24EPS -4.44%·Rev n/aQ4 23EPS +13.46%·Rev n/aQ3 23EPS +17.86%·Rev n/aQ2 23EPS +6.90%·Rev n/a⚠ consensus missing

FATE THERAPEUTICS INC FATE

J. Wolchko — Chief Executive Officer

Edward Dulac — Chief Financial Officer

+4.6%1d on move date+4.5% vs SPY3d+8.2%5d+6.2%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FATE calls or request research access.

More FATE calls Browse calls Request research access